Tag: Jelikalite

JelikaLite Awarded NSF SBIR Phase 1 Grant for EEG-Guided Intelligent Transcranial Photobiomodulation to Reduce Symptoms of Autism
April
29,
2022
We are thrilled to announce that client, JelikaLite, was awarded a National Science Foundation grant SBIR Phase 1: "EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism".
Read More »

JelikaLite, a CNYBAC MDIC 2021 Team, Granted FDA Breakthrough Device Designation:
January
07,
2022
Provided by Business Wire- 1/6/21
NEW YORK--(BUSINESS WIRE)--JelikaLite Corp, a medical technology company, announced today that the U. S.
Read More »